Home
KVK Tech

KVK Tech Market Share Analysis for May 2026

Contact KVK Tech.

Health > Biotechnology and Pharmaceuticals

Domainkvktech.com

Year Founded2004

Employees51 - 200

Annual Revenue$10M - $15M

KVK Tech

KVK Tech (including company regionals)

kvktech.com

See more website traffic and engagement information

KVK Tech Revenue up to May 2026 is 10M - 15M

revenue generated by KVK Tech top domains

KVK Tech top domains revenue over 3 years

Revenue for KVK Tech top domains

kvktech.com10M - 15M

See more with Sales Intelligence

Total visits to KVK Tech's top domains

Understand KVK Tech market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kvktech.com6.6K

See more with Sales Intelligence

Avg. visit duration in KVK Tech's top domains

Analyze KVK Tech engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kvktech.com00:01:58

See more with Sales Intelligence

Avg. pageviews on KVK Tech's top domains

See how KVK Tech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kvktech.com3.63

See more with Sales Intelligence

KVK Tech top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by KVK Tech

These are the website technologies, by industry, used by KVK Tech top domains

Widget (5)

Twemoji

Advertising (1)

PubMatic

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

5

See all

News & Signals from KVK Tech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKVK Tech, Inc. launched cloud-based platform on Jan 1st '15.In 2015, KVK Tech launched its first significant product: a cloud-based platform designed for data management.

NewsKVK Tech, Inc. has issues with False Claims Act arising from the company's failure to exercise appropriate controls.Additionally, KVK Tech agreed to pay $2 million to resolve its civil liability under the False Claims Act arising from the company's failure to exercise appropriate controls as required by current good manufacturing practice regulations, which caused KVK Tech to introduce into interstate commerce drugs deemed to be adulterated.

NewsKVK Tech, Inc. has issues with recall of one lot of Betaxolol Tablets.KVK-Tech, Inc. issues voluntary nationwide recall of one lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a precautionary measure due to a single foreign tablet found during the line clearance after the batch was packaged.